Background: Alzheimer's disease (AD) is characterized by the accumulation of tau protein in the brain, which forms neurofibrillary tangles and contributes to the gradual deterioration of brain function. As a consequence, cellular senescence occurs, leading to cognitive impairment and hastening the aging process. Immunotherapies targeting Aβ and other protein aggregates are also being developed in the meantime. This study looks at immunotherapy in a Mapt (hTau) mouse model. This could become a useful immunological treatment in the future by lowering inflammation and cellular senescence that come with getting older.

Method: Mapt (hTau) mice were inoculated in the hippocampus with 1 µg of brain-derived Tau oligomers (BDTOs) from AD patients. After seven months, mice were injected in the tail vein with 120 µg of in-house mouse monoclonal anti-toxic tau antibodies (TTCM1-2 and TOMA1-4) or IgG isotype control. Mice were evaluated for cognitive and motor function before euthanasia, and brain neuropathology was investigated with immunohistochemistry, immunofluorescence, and western blot techniques.

Result: Treatment with anti-toxic tau antibodies reduced total tau levels and tau phosphorylation in the brain. Furthermore, immunotherapy reduced inflammation and cellular senescence markers.

Conclusion: The observed decrease in tau aggregates following immunotherapy indicates that the mechanisms responsible for tau phosphorylation and/or aggregation may have been altered. Additionally, the decrease in senescence and inflammation markers suggests that immunotherapeutic strategies targeting tau are a promising approach in the management of tauopathies.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.089755DOI Listing

Publication Analysis

Top Keywords

cellular senescence
12
tau
9
mapt htau
8
inflammation cellular
8
anti-toxic tau
8
tau antibodies
8
tau phosphorylation
8
basic science
4
science pathogenesis
4
pathogenesis background
4

Similar Publications

Chondrocyte senescence is an important pathogenic factor causing osteoarthritis (OA) progression through persistently producing pro-inflammatory factors. Mesenchymal stem cells-derived small extracellular vesicles (MSC-sEVs) have shown anti-inflammatory effects in OA models, while persistent existence of senescent chondrocytes still promotes cartilage destruction. Therefore, improving the targeted elimination ability on senescent chondrocytes is required to facilitate the translation of MSC-sEVs in OA treatment.

View Article and Find Full Text PDF

Cell-free hemoglobin released from hemolysis induces programmed cell death through iron overload and oxidative stress in grass carp (Ctenopharyngodon idella).

Fish Shellfish Immunol

January 2025

Guangdong Provincial Water Environment and Aquatic Products Security Engineering Technology Research Center, Guangzhou Key Laboratory of Aquatic Animal Diseases and Waterfowl Breeding, College of Animal Sciences and Technology, Zhongkai University of Agriculture and Engineering, Guangzhou, Guangdong Province 510222, China. Electronic address:

Intravascular hemolysis releases hemoglobin (Hb) from red blood cells under specific conditions, yet the effect of hemolysis in aquaculture systems remain poorly understood. In this study, a continuous hemolysis model for grass carp was established by injection of phenylhydrazine (PHZ) to investigate the mechanistic impacts of sustained hemolysis. PHZ-induced hemolysis altered liver color, and subsequent hematoxylin and eosin staining revealed substantial Hb accumulation in the head kidney, accompanied by inflammatory cell infiltration and vacuolization in liver tissue.

View Article and Find Full Text PDF

CNPY2 modulates senescence-associated secretory phenotype in tendon stem/progenitor cells.

Tissue Cell

December 2024

Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. Electronic address:

Age-related diseases are often linked to chronic inflammation. Senescent cells secrete inflammatory cytokines, chemokines and matrix metalloproteinases, collectively referred to as the senescence-associated secretory phenotype (SASP). The current study discovered that aging leads to the accumulation of senescent tendon stem/progenitor cells (TSPCs) in tendon tissue, resulting in the development of a SASP.

View Article and Find Full Text PDF

Senolytic treatment attenuates immune cell infiltration without improving IAV outcomes in aged mice.

Aging Cell

January 2025

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Aging is a major risk factor for poor outcomes following respiratory infections. In animal models, the most severe outcomes of respiratory infections in older hosts have been associated with an increased burden of senescent cells that accumulate over time with age and create a hyperinflammatory response. Although studies using coronavirus animal models have demonstrated that removal of senescent cells with senolytics, a class of drugs that selectively kills senescent cells, resulted in reduced lung damage and increased survival, little is known about the role that senescent cells play in the outcome of influenza A viral (IAV) infections in aged mice.

View Article and Find Full Text PDF

Aging remains the foremost risk factor for cardiovascular and cerebrovascular diseases, surpassing traditional factors in epidemiological significance. This review elucidates the cellular and molecular mechanisms underlying vascular aging, with an emphasis on sex differences that influence disease progression and clinical outcomes in older adults. We discuss the convergence of aging processes at the macro- and microvascular levels and their contributions to the pathogenesis of vascular diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!